The European COST Action VascAgeNet Fostering Innovation – When Industry Comes to Science

Authors

Christopher C. Mayer^{1, *,} , Rachel E. Climie^{2, 3, 4}, Bernhard Hametner¹, Rosa-Maria Bruno^{2, 5}

¹Center for Health & Bioresources, Biomedical Systems, AIT Austrian Institute of Technology GmbH, Giefinggasse 4, Vienna 1210, Austria

²INSERM U970 Paris-Centre de Recherche Cardiovasculaire (PARCC), Paris, France

³Sports Cardiology and Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia

⁴Blood Pressure Research Group, Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart/Tasmania, Australia

⁵Department of Pharmacology, Université Paris Descartes – Université de Paris, Paris, France

^*Corresponding author. Email: christopher.mayer@ait.ac.at

DOI

10.2991/artres.k.200430.001How to use a DOI?

Keywords

COST action; VascAgeNet; vascular ageing; innovation

Abstract

VascAgeNet is a new European network which will join forces in order to refine, harmonize and promote the vascular ageing concept. It aims to bring innovations in cardiovascular research from bench to bedside and to establish assessment of vascular ageing in clinical practice. The interdisciplinary, inter-country and intersectional approach will enable all important players at the different stages of the innovation process to come together, as recommended in the triple or quadruple helix model of innovation, in order to guarantee best solutions. This is deemed necessary in order for economic and revolutionary solutions to be fit for wide-spread clinical use, especially in low-income and inclusiveness target countries. Thus, a clear case exists for a strong collaboration between science and industry, to foster innovations and breakthroughs in vascular ageing in order to improve clinical practice and to reduce the burden of cardiovascular diseases globally.

Copyright

© 2020 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

TY  - JOUR
AU  - Christopher C. Mayer
AU  - Rachel E. Climie
AU  - Bernhard Hametner
AU  - Rosa-Maria Bruno
PY  - 2020
DA  - 2020/05/04
TI  - The European COST Action VascAgeNet Fostering Innovation – When Industry Comes to Science
JO  - Artery Research
SP  - 125
EP  - 129
VL  - 26
IS  - 3
SN  - 1876-4401
UR  - https://doi.org/10.2991/artres.k.200430.001
DO  - 10.2991/artres.k.200430.001
ID  - Mayer2020
ER  -